Crossmark

The development of the validated LCMS bioanalysis of trastuzumab in human plasma using a selective detection method for complementarity-determining regions of monoclonal antibodies: nano-surface and molecular-orientation limited (nSMOL) proteolysis

Crossref DOI link: https://doi.org/10.1039/C5AY01588J

Published Online: 2015

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Iwamoto, Noriko

Yamane, Naoe

Umino, Yukari

Hamada, Akinobu

Shimada, Takashi
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

COPYRIGHT AND LICENSING

: The Royal Society of Chemistry has an exclusive publication licence for this journal

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 20 June 2015; Accepted 7 September 2015; Accepted Manuscript published 11 September 2015; Advance Article published 6 October 2015; Version of Record published 22 October 2015

Document is current

Any future updates will be listed below